230 related articles for article (PubMed ID: 25899424)
1. Progressive multiple sclerosis and mood disorders.
Lorefice L; Fenu G; Trincas G; Moro MF; Frau J; Coghe GC; Cocco E; Marrosu MG; Carta MG
Neurol Sci; 2015 Sep; 36(9):1625-31. PubMed ID: 25899424
[TBL] [Abstract][Full Text] [Related]
2. Anxiety disorders and their clinical correlates in multiple sclerosis patients.
Korostil M; Feinstein A
Mult Scler; 2007 Jan; 13(1):67-72. PubMed ID: 17294613
[TBL] [Abstract][Full Text] [Related]
3. A comparison of anxiety symptoms and correlates of anxiety in people with progressive and relapsing-remitting multiple sclerosis.
Knowles LM; Tingey JL; Newman AK; von Geldern G; Alschuler KN
Mult Scler Relat Disord; 2022 Jul; 63():103918. PubMed ID: 35700673
[TBL] [Abstract][Full Text] [Related]
4. Role of Demographic and Clinical Factors in Cognitive Functioning of Persons with Relapsing-Remitting and Progressive Multiple Sclerosis.
Costa SL; DeLuca J; Sandroff BM; Goverover Y; Chiaravalloti ND
J Int Neuropsychol Soc; 2018 Feb; 24(2):139-146. PubMed ID: 28830576
[TBL] [Abstract][Full Text] [Related]
5. Differences in correlates of fatigue between relapsing and progressive forms of multiple sclerosis.
Herring TE; Alschuler KN; Knowles LM; Phillips KM; Morean WM; Turner AP; Ehde DM
Mult Scler Relat Disord; 2021 Sep; 54():103109. PubMed ID: 34237561
[TBL] [Abstract][Full Text] [Related]
6. Differential patterns of memory performance in relapsing, remitting and secondary progressive multiple sclerosis.
Drake MA; Carrá A; Allegri RF; Luetic G
Neurol India; 2006 Dec; 54(4):370-6. PubMed ID: 17114845
[TBL] [Abstract][Full Text] [Related]
7. Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample.
Chwastiak L; Ehde DM; Gibbons LE; Sullivan M; Bowen JD; Kraft GH
Am J Psychiatry; 2002 Nov; 159(11):1862-8. PubMed ID: 12411220
[TBL] [Abstract][Full Text] [Related]
8. Multiple sclerosis clinical course and cardiovascular disease risk - Swedish cohort study.
Roshanisefat H; Bahmanyar S; Hillert J; Olsson T; Montgomery S
Eur J Neurol; 2014 Nov; 21(11):1353-e88. PubMed ID: 25041631
[TBL] [Abstract][Full Text] [Related]
9. Social anxiety in a multiple sclerosis clinic population.
Poder K; Ghatavi K; Fisk JD; Campbell TL; Kisely S; Sarty I; Stadnyk K; Bhan V
Mult Scler; 2009 Mar; 15(3):393-8. PubMed ID: 19028833
[TBL] [Abstract][Full Text] [Related]
10. Diabetes and anxiety adversely affect cognition in multiple sclerosis.
Marrie RA; Patel R; Figley CR; Kornelsen J; Bolton JM; Graff L; Mazerolle EL; Marriott JJ; Bernstein CN; Fisk JD;
Mult Scler Relat Disord; 2019 Jan; 27():164-170. PubMed ID: 30384203
[TBL] [Abstract][Full Text] [Related]
11. Fatigue in multiple sclerosis: relationship to depression, disability, and disease pattern.
Kroencke DC; Lynch SG; Denney DR
Mult Scler; 2000 Apr; 6(2):131-6. PubMed ID: 10773860
[TBL] [Abstract][Full Text] [Related]
12. Use of coping strategies in multiple sclerosis: Association with demographic and disease-related characteristics
Holland DP; Schlüter DK; Young CA; Mills RJ; Rog DJ; Ford HL; Orchard K;
Mult Scler Relat Disord; 2019 Jan; 27():214-222. PubMed ID: 30412819
[TBL] [Abstract][Full Text] [Related]
13. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
[TBL] [Abstract][Full Text] [Related]
14. Demographic and clinical profile of Multiple Sclerosis in Kashmir: A short report.
Zahoor I; Asimi R; Haq E; Yousuf Wani I
Mult Scler Relat Disord; 2017 Apr; 13():103-106. PubMed ID: 28427689
[TBL] [Abstract][Full Text] [Related]
15. Long-term influence of combined oral contraceptive use on the clinical course of relapsing-remitting multiple sclerosis.
Gava G; Bartolomei I; Costantino A; Berra M; Venturoli S; Salvi F; Meriggiola MC
Fertil Steril; 2014 Jul; 102(1):116-22. PubMed ID: 24794311
[TBL] [Abstract][Full Text] [Related]
16. Is malnutrition a problem for multiple sclerosis patients?
Sorgun MH; Yucesan C; Tegin C
J Clin Neurosci; 2014 Sep; 21(9):1603-5. PubMed ID: 24932588
[TBL] [Abstract][Full Text] [Related]
17. [The role of brain glucose metabolism in the development of cognitive dysfunctions in patients with remitting and secondary-progressive multiple sclerosis].
Shkil'niuk GG; Il'ves AG; Kataeva GV; Prakhova LN; Reznikova TN; Seliverstova NA; Stoliarov ID
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(2 Pt 2):41-6. PubMed ID: 22677678
[TBL] [Abstract][Full Text] [Related]
18. Olfactory dysfunction in multiple sclerosis: association with secondary progression.
Silva AM; Santos E; Moreira I; Bettencourt A; Coutinho E; Gonçalves A; Pinto C; Montalban X; Cavaco S
Mult Scler; 2012 May; 18(5):616-21. PubMed ID: 22020420
[TBL] [Abstract][Full Text] [Related]
19. Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register.
Bergamaschi R; Beghi E; Bosetti C; Ponzio M; Santucci C; Lepore V; Mosconi P; ; Aguglia U; Amato MP; Ancona AL; Ardito B; Avolio C; Balgera R; Banfi P; Barcella V; Barone P; Bellantonio P; Berardinelli A; Bergamaschi R; Bertora P; Bianchi M; Bramanti P; Morra VB; Brichetto G; Brioschi AM; Buccafusca M; Bucello S; Busillo V; Calchetti B; Cantello R; Capobianco M; Capone F; Capone L; Cargnelutti D; Carrozzi M; Cartechini E; Cavaletti G; Cavalla P; Celani MG; Clerici R; Clerico M; Cocco E; Confalonieri P; Coniglio MG; Conte A; Corea F; Cottone S; Crociani P; D'Andrea F; Danni MC; De Luca G; de Pascalis D; De Riz M; De Robertis F; De Rosa G; De Stefano N; Corte MD; Di Sapio A; Docimo R; Falcini M; Falcone N; Fermi S; Ferraro E; Ferrò MT; Fortunato M; Foschi M; Gajofatto A; Gallo A; Gallo P; Gatto M; Gazzola P; Giordano A; Granella F; Grasso MF; Grasso MG; Grimaldi LME; Iaffaldano P; Imperiale D; Inglese M; Iodice R; Leva S; Luezzi V; Lugaresi A; Lus G; Maimone D; Mancinelli L; Maniscalco GT; Marfia GA; Marini B; Marson A; Mascoli N; Massacesi L; Melani F; Merello M; Meucci G; Mirabella M; Montepietra S; Nasuelli D; Nicolao P; Passantino F; Patti F; Peresson M; Pesci I; Piantadosi C; Piras ML; Pizzorno M; Plewnia K; Pozzilli C; Protti A; Quatrale R; Realmuto S; Ribizzi G; Rinalduzzi S; Rini A; Romano S; Romeo M; Ronzoni M; Rossi P; Rovaris M; Salemi G; Santangelo G; Santangelo M; Santuccio G; Sarchielli P; Sinisi L; Sola P; Solaro C; Spitaleri D; Strumia S; Tassinari T; Tonietti S; Tortorella C; Totaro R; Tozzo A; Trivelli G; Ulivelli M; Valentino P; Venturi S; Vianello M; Zaffaroni M; Zarbo R; Trojano M; Battaglia MA; Capobianco M; Pugliatti M; Ulivelli M; Mosconi P; Gasperini C; Patti F; Amato MP; Bergamaschi R; Comi G
Neurol Sci; 2022 Sep; 43(9):5459-5469. PubMed ID: 35672479
[TBL] [Abstract][Full Text] [Related]
20. Mood and anxiety disorders in patients with multiple sclerosis.
Uguz F; Akpinar Z; Ozkan I; Tokgoz S
Int J Psychiatry Clin Pract; 2008; 12(1):19-24. PubMed ID: 24916492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
